Summary & Research Interests
Professor Koeller is currently a full professor and member of the Center for Pharmacoeconomic Studies in the College of Pharmacy at The University of Texas at Austin, where he holds the Eli Lilly/CR Sublett Endowed Fellowship in Pharmacy. In addition, Professor Koeller is a clinical professor of medicine and oncology at the University of Texas Health Science Center in San Antonio. Prior to moving to Texas, he spent five years coordinating the Phase I Drug Development Program in the Department of Human Oncology, Wisconsin Comprehensive Cancer Center in Madison, Wisconsin. Professor Koeller has published more than 250 articles, abstracts and book chapters in the areas of oncology practice, pharmacoecomonics, new drug development and supportive care issues of the cancer patient. In addition, he has given more than 500 presentations related to oncology, supportive care, pharmacoeconomics, cancer disease management and health care economics.
Koeller's research focuses on cancer care economics. He has worked with private practice clinics and hospital clinics. His research group has performed numerous disease treatment maps for advanced lung, colon and breast cancer. His team currently is looking at the economics of standardized cancer disease treatment strategies.
Education & Research Ctr.
College of Pharmacy
The University of Texas
Health Science Center
7703 Floyd Curl Drive - MC 6220
San Antonio, TX
Email Address: pharmacy
Dr. Kelly Reveles, assistant professor of pharmacotherapy, is primary author of a study which found that the incidence of Clostridium difficile infection (CDI), a highly contagious gastrointestinal disease often linked to the overprescribing of antibiotics, nearly doubled between 2001 and 2010. It also determined there were no improvements in patient health outcomes, including mortality or hospital length of stay, over the study period.